Acetylsalicylic acid decreases tau phosphorylation at serine 422

Neuroscience Letters

Volumn 396, Issue 1, 2006, Pages 77-80

  Tortosa, E ^a   Avila, J ^a   Perez M ^a  

^a UNIVERSIDAD AUTÓNOMA DE MADRID   (Spain)

Author keywords

Acetylsalicylic acid; Serine 422; Tau

Indexed keywords

ACETYLSALICYLIC ACID; OKADAIC ACID; SERINE; TAU PROTEIN;

ANTIINFLAMMATORY ACTIVITY; ARTICLE; CELL STRAIN; CONTROLLED STUDY; HUMAN; HUMAN CELL; NEUROPROTECTION; PRIORITY JOURNAL; PROTEIN LOCALIZATION; PROTEIN MODIFICATION; PROTEIN PHOSPHORYLATION;

ALZHEIMER DISEASE; AMINO ACID SEQUENCE; ANTI-INFLAMMATORY AGENTS, NON-STEROIDAL; ASPIRIN; BRAIN; CELL LINE, TUMOR; DOWN-REGULATION; HUMANS; NEURONS; PHOSPHORYLATION; SERINE; TAU PROTEINS;

EID: 32544457733     PISSN: 03043940     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.neulet.2005.11.066     Document Type: Article

References (23)

1. J. Avila, J.J. Lucas, M. Perez, and F. Hernandez Role of tau protein in both physiological and pathological conditions Physiol. Rev. 84 2004 361 384
2. J.L. Biedler, S. Roffler-Tarlov, M. Schachner, and L.S. Freedman Multiple neurotransmitter synthesis by human neuroblastoma cell lines and clones Cancer Res. 38 1978 3751 3757
3. J. De Cristobal, A. Cardenas, I. Lizasoain, J.C. Leza, P. Fernandez-Tome, P. Lorenzo, and M.A. Moro Inhibition of glutamate release via recovery of ATP levels accounts for a neuroprotective effect of aspirin in rat cortical neurons exposed to oxygen-glucose deprivation Stroke 33 2002 261 267
4. D.L. DeWitt, E.A. el-Harith, S.A. Kraemer, M.J. Andrews, E.F. Yao, R.L. Armstrong, and W.L. Smith The aspirin and heme-binding sites of ovine and murine prostaglandin endoperoxide synthases J. Biol. Chem. 265 1990 5192 5198
5. G. Drewes, E.M. Mandelkow, K. Baumann, J. Goris, W. Merlevede, and E. Mandelkow Dephosphorylation of tau protein and Alzheimer paired helical filaments by calcineurin and phosphatase-2A FEBS Lett. 336 1993 425 432
6. B. Frantz, and E.A. O'Neill The effect of sodium salicylate and aspirin on NF-kappa B Science 270 1995 2017 2019
7. I. Grundke-Iqbal, K. Iqbal, L. George, Y.C. Tung, K.S. Kim, and H.M. Wisniewski Amyloid protein and neurofibrillary tangles coexist in the same neuron in Alzheimer disease Proc. Natl. Acad. Sci. U.S.A. 86 1989 2853 2857
8. G. Halliday, S.R. Robinson, C. Shepherd, and J. Kril Alzheimer's disease and inflammation: a review of cellular and therapeutic mechanisms Clin. Exp. Pharmacol. Physiol. 27 2000 1 8
9. L. Ho, D. Purohit, V. Haroutunian, J.D. Luterman, F. Willis, J. Naslund, J.D. Buxbaum, R.C. Mohs, P.S. Aisen, and G.M. Pasinetti Neuronal cyclooxygenase 2 expression in the hippocampal formation as a function of the clinical progression of Alzheimer disease Arch. Neurol. 58 2001 487 492
10. K. Kadoyama, Y. Takahashi, H. Higashida, T. Tanabe, and T. Yoshimoto Cyclooxygenase-2 stimulates production of amyloid beta-peptide in neuroblastoma x glioma hybrid NG108-15 cells Biochem. Biophys. Res. Commun. 281 2001 483 490
11. M. Morishima-Kawashima, M. Hasegawa, K. Takio, M. Suzuki, H. Yoshida, K. Titani, and Y. Ihara Proline-directed and non-proline-directed phosphorylation of PHF-tau J. Biol. Chem. 270 1995 823 829
12. M. Novak, R. Jakes, P.C. Edwards, C. Milstein, and C.M. Wischik Difference between the tau protein of Alzheimer paired helical filament core and normal tau revealed by epitope analysis of monoclonal antibodies 423 and 7.51 Proc. Natl. Acad. Sci. U.S.A. 88 1991 5837 5841
13. G. Perry, H. Roder, A. Nunomura, A. Takeda, A.L. Friedlich, X. Zhu, A.K. Raina, N. Holbrook, S.L. Siedlak, P.L. Harris, and M.A. Smith Activation of neuronal extracellular receptor kinase (ERK) in Alzheimer disease links oxidative stress to abnormal phosphorylation NeuroReport 10 1999 2411 2415
14. R.N. Pinckard, D. Hawkins, and R.S. Farr In vitro acetylation of plasma proteins, enzymes and DNA by aspirin Nature 219 1968 68 69
15. M. Rapoport, H.N. Dawson, L.I. Binder, M.P. Vitek, and A. Ferreira Tau is essential to beta-amyloid-induced neurotoxicity Proc. Natl. Acad. Sci. U.S.A. 99 2002 6364 6369
16. H.M. Roder, P.A. Eden, and V.M. Ingram Brain protein kinase PK40erk converts TAU into a PHF-like form as found in Alzheimer's disease Biochem. Biophys. Res. Commun. 193 1993 639 647
17. G.J. Roth, N. Stanford, and P.W. Majerus Acetylation of prostaglandin synthase by aspirin Proc. Natl. Acad. Sci. U.S.A. 72 1975 3073 3076
18. P. Schwenger, E.Y. Skolnik, and J. Vilcek Inhibition of tumor necrosis factor-induced p42/p44 mitogen-activated protein kinase activation by sodium salicylate J. Biol. Chem. 271 1996 8089 8094
19. P. Seubert, M. Mawal-Dewan, R. Barbour, R. Jakes, M. Goedert, G.V. Johnson, J.M. Litersky, D. Schenk, I. Lieberburg, J.Q. Trojanowski, and V.M.-Y. Lee Detection of phosphorylated Ser262 in fetal tau, adult tau, and paired helical filament tau J. Biol. Chem. 270 1995 18917 18922
20. J.R. Vane, and R.M. Botting Anti-inflammatory drugs and their mechanism of action Inflamm. Res. 47 Suppl. 2 1998 S78 S87
21. N. Vartiainen, G. Goldsteins, V. Keksa-Goldsteine, P.H. Chan, and J. Koistinaho Aspirin inhibits p44/42 mitogen-activated protein kinase and is protective against hypoxia/reoxygenation neuronal damage Stroke 34 2003 752 757
22. Z. Wang, B. Jiang, and P. Brecher Selective inhibition of STAT3 phosphorylation by sodium salicylate in cardiac fibroblasts Biochem. Pharmacol. 63 2002 1197 1207
23. J. Zhong, K. Iqbal, and I. Grundke-Iqbal Hyperphosphorylated tau in SY5Y cells: similarities and dissimilarities to abnormally hyperphosphorylated tau from Alzheimer disease brain FEBS Lett. 453 1999 224 228